TNSN02003A1 - Association d'un antagoniste des recepteurs d'histamine h1 et d'un antagoniste selectif des recepteurs d'histamine h4, et composition la contenant. - Google Patents
Association d'un antagoniste des recepteurs d'histamine h1 et d'un antagoniste selectif des recepteurs d'histamine h4, et composition la contenant.Info
- Publication number
- TNSN02003A1 TNSN02003A1 TNTNSN02003A TNSN02003A TNSN02003A1 TN SN02003 A1 TNSN02003 A1 TN SN02003A1 TN TNSN02003 A TNTNSN02003 A TN TNSN02003A TN SN02003 A TNSN02003 A TN SN02003A TN SN02003 A1 TNSN02003 A1 TN SN02003A1
- Authority
- TN
- Tunisia
- Prior art keywords
- histamine
- antagonist
- combination
- composition containing
- same
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 229940124056 Histamine H1 receptor antagonist Drugs 0.000 title 1
- 239000000938 histamine H1 antagonist Substances 0.000 title 1
- 239000003396 histamine H4 receptor antagonist Substances 0.000 title 1
- 239000005557 antagonist Substances 0.000 abstract 2
- 102000003834 Histamine H1 Receptors Human genes 0.000 abstract 1
- 108090000110 Histamine H1 Receptors Proteins 0.000 abstract 1
- 102000004384 Histamine H3 receptors Human genes 0.000 abstract 1
- 108090000981 Histamine H3 receptors Proteins 0.000 abstract 1
- 102000004187 Histamine H4 receptors Human genes 0.000 abstract 1
- 108090000796 Histamine H4 receptors Proteins 0.000 abstract 1
- 206010039085 Rhinitis allergic Diseases 0.000 abstract 1
- 201000009961 allergic asthma Diseases 0.000 abstract 1
- 201000010105 allergic rhinitis Diseases 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0101223.6A GB0101223D0 (en) | 2001-01-17 | 2001-01-17 | Histamine receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TNSN02003A1 true TNSN02003A1 (fr) | 2005-12-23 |
Family
ID=9906993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNTNSN02003A TNSN02003A1 (fr) | 2001-01-17 | 2002-01-16 | Association d'un antagoniste des recepteurs d'histamine h1 et d'un antagoniste selectif des recepteurs d'histamine h4, et composition la contenant. |
Country Status (31)
| Country | Link |
|---|---|
| EP (1) | EP1353657A1 (xx) |
| JP (1) | JP2004517883A (xx) |
| KR (1) | KR20030069216A (xx) |
| CN (1) | CN1486178A (xx) |
| AP (1) | AP2002002401A0 (xx) |
| AR (1) | AR032101A1 (xx) |
| BG (1) | BG107834A (xx) |
| BR (1) | BR0206502A (xx) |
| CA (1) | CA2435121A1 (xx) |
| CR (1) | CR6983A (xx) |
| CZ (1) | CZ20031853A3 (xx) |
| DO (1) | DOP2002000325A (xx) |
| EA (1) | EA200300537A1 (xx) |
| EC (1) | ECSP034692A (xx) |
| EE (1) | EE200300335A (xx) |
| GB (1) | GB0101223D0 (xx) |
| GT (1) | GT200200003A (xx) |
| HU (1) | HUP0302767A2 (xx) |
| IL (1) | IL156087A0 (xx) |
| IS (1) | IS6818A (xx) |
| MA (1) | MA26980A1 (xx) |
| MX (1) | MXPA03006408A (xx) |
| NO (1) | NO20033223D0 (xx) |
| OA (1) | OA12440A (xx) |
| PA (1) | PA8537101A1 (xx) |
| PL (1) | PL362793A1 (xx) |
| SK (1) | SK8572003A3 (xx) |
| SV (1) | SV2003000849A (xx) |
| TN (1) | TNSN02003A1 (xx) |
| WO (1) | WO2002056871A2 (xx) |
| ZA (1) | ZA200304180B (xx) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030133931A1 (en) * | 2001-12-21 | 2003-07-17 | Robin Thurmond | Use of histamine H4 receptor antagonist for the treatment of inflammatory responses |
| CA2497788A1 (en) * | 2002-09-06 | 2004-03-18 | Janssen Pharmaceutica, N.V. | Use of histamine h4 receptor modulators for the treatment of allergy and asthma |
| WO2004066960A2 (en) * | 2003-01-28 | 2004-08-12 | Schering Corporation | Combination of h1, h3 and h4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis |
| US8236786B2 (en) | 2008-08-07 | 2012-08-07 | Pulmagen Therapeutics (Inflammation) Limited | Respiratory disease treatment |
| WO2013151982A1 (en) | 2012-04-03 | 2013-10-10 | Arena Pharmaceuticals, Inc. | Methods and compounds useful in treating pruritus, and methods for identifying such compounds |
| ES2683380T3 (es) | 2012-06-08 | 2018-09-26 | Sensorion | Inhibidores del receptor H4 para tratar el tinnitus |
| CN119823227B (zh) * | 2025-01-14 | 2025-07-04 | 广州迪卡德营养科技有限公司 | 一种益生菌的制备方法及其在治疗过敏性鼻炎中的用途 |
-
2001
- 2001-01-17 GB GBGB0101223.6A patent/GB0101223D0/en not_active Ceased
-
2002
- 2002-01-10 BR BR0206502-9A patent/BR0206502A/pt not_active IP Right Cessation
- 2002-01-10 EA EA200300537A patent/EA200300537A1/ru unknown
- 2002-01-10 SK SK857-2003A patent/SK8572003A3/sk unknown
- 2002-01-10 CN CNA028036840A patent/CN1486178A/zh active Pending
- 2002-01-10 MX MXPA03006408A patent/MXPA03006408A/es unknown
- 2002-01-10 KR KR10-2003-7009493A patent/KR20030069216A/ko not_active Ceased
- 2002-01-10 CA CA002435121A patent/CA2435121A1/en not_active Abandoned
- 2002-01-10 EE EEP200300335A patent/EE200300335A/xx unknown
- 2002-01-10 WO PCT/IB2002/000042 patent/WO2002056871A2/en not_active Ceased
- 2002-01-10 PL PL02362793A patent/PL362793A1/xx not_active Application Discontinuation
- 2002-01-10 CZ CZ20031853A patent/CZ20031853A3/cs unknown
- 2002-01-10 IL IL15608702A patent/IL156087A0/xx unknown
- 2002-01-10 JP JP2002557379A patent/JP2004517883A/ja not_active Withdrawn
- 2002-01-10 HU HU0302767A patent/HUP0302767A2/hu unknown
- 2002-01-10 OA OA1200300174A patent/OA12440A/en unknown
- 2002-01-10 EP EP02732099A patent/EP1353657A1/en not_active Withdrawn
- 2002-01-11 DO DO2002000325A patent/DOP2002000325A/es unknown
- 2002-01-14 PA PA20028537101A patent/PA8537101A1/es unknown
- 2002-01-16 SV SV2002000849A patent/SV2003000849A/es not_active Application Discontinuation
- 2002-01-16 GT GT200200003A patent/GT200200003A/es unknown
- 2002-01-16 TN TNTNSN02003A patent/TNSN02003A1/fr unknown
- 2002-01-16 AR ARP020100145A patent/AR032101A1/es not_active Application Discontinuation
- 2002-01-17 AP APAP/P/2002/002401A patent/AP2002002401A0/en unknown
-
2003
- 2003-05-15 IS IS6818A patent/IS6818A/is unknown
- 2003-05-21 BG BG107834A patent/BG107834A/bg unknown
- 2003-05-22 CR CR6983A patent/CR6983A/es not_active Application Discontinuation
- 2003-05-29 ZA ZA200304180A patent/ZA200304180B/en unknown
- 2003-07-11 MA MA27233A patent/MA26980A1/fr unknown
- 2003-07-16 NO NO20033223A patent/NO20033223D0/no not_active Application Discontinuation
- 2003-07-17 EC EC2003004692A patent/ECSP034692A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GT200200003A (es) | 2002-08-19 |
| ECSP034692A (es) | 2003-08-29 |
| DOP2002000325A (es) | 2003-01-31 |
| CR6983A (es) | 2003-11-25 |
| PL362793A1 (en) | 2004-11-02 |
| NO20033223L (no) | 2003-07-16 |
| CA2435121A1 (en) | 2002-07-25 |
| KR20030069216A (ko) | 2003-08-25 |
| BG107834A (bg) | 2004-01-30 |
| MXPA03006408A (es) | 2003-10-15 |
| MA26980A1 (fr) | 2004-12-20 |
| EA200300537A1 (ru) | 2004-02-26 |
| SV2003000849A (es) | 2003-01-13 |
| OA12440A (en) | 2006-05-22 |
| HUP0302767A2 (hu) | 2003-11-28 |
| EE200300335A (et) | 2003-12-15 |
| PA8537101A1 (es) | 2002-08-29 |
| GB0101223D0 (en) | 2001-02-28 |
| ZA200304180B (en) | 2004-06-15 |
| IS6818A (is) | 2003-05-15 |
| WO2002056871A2 (en) | 2002-07-25 |
| EP1353657A1 (en) | 2003-10-22 |
| CN1486178A (zh) | 2004-03-31 |
| JP2004517883A (ja) | 2004-06-17 |
| AP2002002401A0 (en) | 2002-03-31 |
| SK8572003A3 (en) | 2004-07-07 |
| AR032101A1 (es) | 2003-10-22 |
| BR0206502A (pt) | 2003-10-21 |
| NO20033223D0 (no) | 2003-07-16 |
| IL156087A0 (en) | 2003-12-23 |
| CZ20031853A3 (cs) | 2004-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TNSN02018A1 (fr) | COMPOSITIONS COMPRENANT UN AGONISTE INVERSE DE GABAa, ET UN AGONISTE PARTIEL DES RECEPTEURS DE NICOTINE, UN OESTROGENE, UN MODULATEUR SELECTIF DES RECEPTEURS D'OESTROGENE OU DE LA VITAMINE E | |
| TNSN01068A1 (fr) | Compositions pharmaceutiques pour le traitement de maladies comportant un dysfonctionnement cognitif | |
| TNSN01053A1 (fr) | Compositions nouvelles comprenant un agoniste partiel des recepteurs de nicotine et un agent analgesique | |
| FR2814678B1 (fr) | Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite | |
| DE69531998D1 (de) | Steroidrezeptor-modulator verbindungen und methoden | |
| DE60205234D1 (de) | 1,2,3,4-tetrahydroisochinolin-derivate als urotensin ii rezeptor-antagonisten | |
| MA27028A1 (fr) | Agoniste de recepteur d'adenosine a2a et agent anticholinergique en association pour le traitement de maladies obstructives des voies aeriennes | |
| TNSN98017A1 (fr) | Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
| TNSN00183A1 (fr) | COMPOSITIONS COMPRENANT LE POLYPEPTIDE IL-1ra ET UN INHIBITEUR DE MATURATION ET DE LIBERATION DE IL-1 ET METHODES DE TRAITEMENT LES UTILISANT | |
| TNSN01040A1 (fr) | Compositions nouvelles comprenant des inhibiteurs de glycogene- phosphorylase | |
| TNSN01173A1 (fr) | Compositions pharmaceutiques comprenant un antagoniste des recepteurs de nmda. | |
| MA31089B1 (fr) | Anticorps anti-notch3 antagonistes et utilisations de ces derniers dans la prophylaxie et le traitement de maladies liees a notch3 | |
| MA31016B1 (fr) | Composes de diazepan substitues comme antagonistes des recepteurs de l'orexine. | |
| TNSN98227A1 (fr) | Association pharmaceutique pour le traitement d'un dysfonctionnement sexuel et compositions la contenant. | |
| BR9813957A (pt) | Uso de antagonistas da vasopressina | |
| TNSN02003A1 (fr) | Association d'un antagoniste des recepteurs d'histamine h1 et d'un antagoniste selectif des recepteurs d'histamine h4, et composition la contenant. | |
| NO20035025L (no) | Anvendelse av osteopontin for behandling og/eller for a hindre nevrologiske sykdommer, samt farmasoytisk sammensetning omfattende osteopontin eller en antagonist med osteopontinaktivitet. | |
| MA27101A1 (fr) | Composition pharmaceutique orodispersible d'agomelatine | |
| MA29487B1 (fr) | Preparation de type emulsion stable | |
| ATE237321T1 (de) | 20-hete antagonisten und agonisten | |
| BR0015980A (pt) | Agente para profilaxia ou tratamento do glaucoma, e, uso de um antagonista de angiotensina ii | |
| ATE266420T1 (de) | Kombinationspräparat, das selektive nmda nr2b- antagonisten und cox-2 inhibitoren enthält | |
| ATE348812T1 (de) | Chinolin- und chinazolinderivate als antagonisten des corticotropin freisetzenden faktors (crf) | |
| YU39201A (sh) | Upotreba 1-arilpirazola za pripremanje oralnog sredstva za suzbijanje parazita | |
| ATE260278T1 (de) | 5ht1 rezeptor antagonisten und ihre verwendung für die behandlung von depression |